- Home
- BWLP vs EVO Comparison
BWLP vs EVO Comparison
Compare BWLP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- EVO
- Stock Information
- Founded
- BWLP 1935
- EVO 1993
- Country
- BWLP Singapore
- EVO Germany
- Employees
- BWLP N/A
- EVO N/A
- Industry
- BWLP Marine Transportation
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- EVO Health Care
- Exchange
- BWLP Nasdaq
- EVO Nasdaq
- Market Cap
- BWLP 1.6B
- EVO 1.5B
- IPO Year
- BWLP N/A
- EVO 2021
- Fundamental
- Price
- BWLP $12.50
- EVO $4.08
- Analyst Decision
- BWLP
- EVO Buy
- Analyst Count
- BWLP 0
- EVO 2
- Target Price
- BWLP N/A
- EVO $5.90
- AVG Volume (30 Days)
- BWLP 428.2K
- EVO 117.0K
- Earning Date
- BWLP 08-27-2025
- EVO 08-13-2025
- Dividend Yield
- BWLP 13.60%
- EVO N/A
- EPS Growth
- BWLP N/A
- EVO N/A
- EPS
- BWLP 1.86
- EVO N/A
- Revenue
- BWLP $3,387,328,000.00
- EVO $851,944,444.00
- Revenue This Year
- BWLP N/A
- EVO $10.08
- Revenue Next Year
- BWLP $2.04
- EVO $10.99
- P/E Ratio
- BWLP $7.23
- EVO N/A
- Revenue Growth
- BWLP 9.53
- EVO 1.50
- 52 Week Low
- BWLP $7.86
- EVO $2.84
- 52 Week High
- BWLP $19.36
- EVO $5.64
- Technical
- Relative Strength Index (RSI)
- BWLP 65.89
- EVO 57.98
- Support Level
- BWLP $11.58
- EVO $4.15
- Resistance Level
- BWLP $12.18
- EVO $4.35
- Average True Range (ATR)
- BWLP 0.30
- EVO 0.11
- MACD
- BWLP 0.01
- EVO 0.03
- Stochastic Oscillator
- BWLP 97.87
- EVO 98.39
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.